Thyrocare Technologies Q4 Results
- BSE: 539871
- NSE: THYROCARE
- ISIN: INE594H01019
- Sector: Healthcare Facilities
BSE
528.80
-1.70 (-0.32%)
-1.70 (-0.32%)Volume5.51 K
Updated: Thu 16 Jul, 2026 | 11:08:51
NSE
530.250.00 (0.00%)
0.00 (0.00%)Volume39.36 K
Updated: Thu 16 Jul, 2026 | 10:54:25
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹223.95 Cr.(19.66%)
- Operating Profit₹61.06 Cr.(39.03%)
- Profit After Tax₹47.11 Cr.(117.20%)
- Operating Margin27.27%(16.19%)
Note: Comparison is on YoY basis
Quarterly - Thyrocare Technologies Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 162.89 | 165.49 | -1.57% | 132.54 | 13.72% |
| Depreciation/ Amortization | 14.03 | 21.63 | -35.14% | 13.06 | 1.89% |
| Operating Income | 61.06 | 30.04 | 103.26% | 21.71 | 39.03% |
| Net Income | 47.11 | 29.01 | 62.39% | 17.78 | 117.20% |
| Other Operating Expenses Total | 57.98 | 54.74 | 5.92% | 37.51 | 28.08% |
| Net Income Before Taxes | 64.43 | 35.39 | 82.06% | 22.91 | 36.56% |
| Total Revenue | 223.95 | 195.53 | 14.53% | 154.25 | 19.66% |
| Selling/ General/ Admin Expenses Total | 34.20 | 35.76 | -4.36% | 35.40 | -1.50% |
| Diluted Normalized EPS | 2.95 | 2.11 | 39.69% | 1.20 | 105.57% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.